Nuclear factor-B (NF-B) plays a central role in myocardial ischemia-reperfusion (MI/R) injury. The inhibitory protein IB␣ prevents its activation. We investigated the effects of adeno-associated viral vector-mediated IB␣ gene transfer in MI/R injury. Male C57BL/6 mice were randomized to receive a recombinant adeno-associated virus (rAAV) encoding the gene for the NF-B inhibitory protein IB␣ (rAAV-IB␣) or the ␤-galactosidase gene (a control and inert gene; rAAV-LacZ), both at a dose of 10 11 copies. Four weeks later anesthetized animals were subjected to total occlusion (45 minutes) of the left main coronary artery followed by 5 hours of reperfusion. MI/R produced a wide infarct size (IF/area-at-risk ϭ 56 Ϯ 8%; IF/left ventricle ϭ 44 Ϯ 5%) and tissue neutrophil infiltration, studied by means of elastase activity (area-at-risk ϭ 2.5 Ϯ 0.4 g/gm tissue; infarct area ϭ 2.9 Ϯ 0.6 g/gm tissue). Furthermore MI/R caused peak message for intercellular adhesion molecule-1 (ICAM-1) in the area-at-risk at 3 hours of reperfusion (1.2 Ϯ 0.4 relative amount of cardiac ICAM-1 mRNA). NF-B activation was evident at 0.5 hours of reperfusion and reached its maximum increase at 2 hours of reperfusion. rAAV-IB␣ injection reduced infarct size (IF/area-at-risk ϭ 19 Ϯ 3%; IF/left ventricle ϭ 10 Ϯ 2%; p Ͻ 0.001), blocked NF-B activation, diminished cardiac ICAM-1 expression (0.4 Ϯ 0.02 relative amount of cardiac ICAM-1 mRNA; p Ͻ 0.001), and blunted leukocyte accumulation (area-at-risk ϭ 0.6 Ϯ 0.05 g/gm tissue; infarct area ϭ 0.4 Ϯ 0.02 g/gm tissue; p Ͻ 0.001). Our data indicate that rAAV-IB␣ may be useful for MI/R gene therapy. (Lab Invest 2003, 83:1097-1104.
R
eperfusion of coronary arteries with thrombolytic agents (Stampfer et al, 1982) or angioplasty (Stone et al, 1998; Zahn et al, 1997) markedly reduces mortality and improves left ventricular function in acute myocardial infarction. However acute myocardial infarction is still the leading cause of death in developed countries. Reperfusion after even brief periods of ischemia is associated with pathologic changes that represent either an acceleration of processes initiated during ischemia, per se, or new changes initiated during the reperfusion (Braun, 1985; Lucchesi, 1990; Muller et al, 1990) .
Indeed ischemia-reperfusion triggers a release of reactive oxygen species (McCord, 1987) , cytokines (Ikeda et al, 1994; Squadrito et al, 1993) , and other proinflammatory mediators that activate leukocytes, endothelial cells, and myocytes. Such activation promotes the expression of adhesion molecules on the endothelium and myocardium Ioculano et al, 1994) ; adhesion molecules recruit neutrophils to the surface of the endothelium and myocardium and prompt a specific cascade of cell-cell interaction, leading first to the adherence of neutrophils to the endothelium and then to trans-endothelial migration and direct interaction with myocytes (Lucchesi, 1991; Mullane, 1991) .
Nuclear factor-B (NF-B) is an early transcription factor that modulates gene expression in various situations that require rapid and sensitive immune and inflammatory response. The prototypic inducible form of NF-B is composed of NF-B1 and Rel A, which both belong to the NF-B/Rel family of proteins. Inactive NF-B is present in the cytoplasm complexed with the inhibitory protein IB␣. NF-B is activated by a number of incoming signals from the cell surface. Released from IB␣ inhibition, NF-B translocates into the nucleus and binds to the B motif of the target gene, in turn causing activation of several factors (cell adhesion molecules, cytokines) involved in the inflam-matory response (Ghosh et al, 1998; Gius et al, 1999; Lee and Burckart, 1998) .
It has been suggested that in myocardial ischemiareperfusion (MI/R) injury, NF-B activates the inflammatory cascade, leading to the expression of cell adhesion molecules and cytokines and finally culminating in the deleterious accumulation of leukocytes in the ischemic myocardium (Chandrasekar et al, 2001a; Sun et al, 2001; Thourani et al, 2000) . This suggests that this transcription factor may represent a new therapeutic target for myocardial protection (Valen et al, 2001) . Indeed blockade of NF-B activation by using several pharmacologic strategies has been successful in reducing myocardial damage and attenuating leukocyte infiltration in the ischemic myocardium (Valen et al, 2001 ).
The heart is an ideal organ for in vivo gene transfer (Su et al, 2000) . Several gene delivery procedures have been used to investigate myocardial gene transfer in vivo, including the use of viral and nonviral methods. Among the novel strategies that hold promise for therapeutic gene therapy application is the use of vectors based on the adeno-associated virus (AAV). These vectors are derived from a nonpathogenetic and widespread defective parvovirus and are able to transfect both dividing and nondividing cells including cardiac muscle cells. These vectors have been found to be highly efficient for in vivo gene transfer to the mouse heart (Su et al, 2000) . Furthermore, because recombinant adeno-associated virus (rAAV) vectors are devoid of any viral genes, which are expressed in trans for the packaging process, they elicit virtually no inflammatory or immune response in the sites of injection (Grimm et al, 1998) .
In the present study we investigated the effect of AAV-mediated IB␣ (the inhibitory protein of NF-B) delivery in mice subjected to MI/R injury.
Results

Transgene Expression of rAAV-IB␣ in the Mouse Heart
In a effort to determine the time course of rAAV-IB␣ expression in mouse heart, mice were treated with an intracardiac injection of rAAV-LacZ or rAAV-IB␣. Animals were killed 4 and 8 weeks after treatment, and a Western blotting analysis was performed with an antibody reacting with IB␣. Animals treated with rAAV-IB␣ showed an enhanced expression of the inhibitory protein (Fig. 1) .
Reduced Myocardial Infarct Size After Treatment with rAAV-IBa
The area-at-risk (AAR) showed no significant differences between each of the experimental group (Fig.  2) , indicating that a similar amount of tissue was jeopardized by the occlusion of the left anterior descending artery (LAD) in each group. In the MI/R rAAV-LacZ and PBS groups, the infarct size, expressed either as a percentage of AAR or as a percentage of the left ventricle, was significantly increased. Administration of rAAV-IB␣ markedly reduced the extension of infarct size (Fig. 2) .
Serum creatinine phosphokinase showed a marked and significant increase in MI/R animals treated with the reporter gene LacZ or PBS. In contrast the gene transfer of the IB␣ protein blunted the rise in serum creatinine phosphokinase (Table 1) .
Myocardial Elastase (ELA) Levels in Mice Subjected to the rAAV-Mediated Gene Transfer of IBa
High ELA activities were found both in the AAR and in the infarct area of the MI/R group treated with rAAVLacZ or PBS. However, rAAV-mediated gene transfer of IB␣ reduced tissue ELA levels in both the AAR and the infarct area (Table 1) . ELA values, in the nonischemic myocardium, ranged between 0.22 and 0.33 g/gm tissue in each group. There were no significant differences in ELA contents among groups (Table 1 ). Basal expression of IB␣ was significantly augmented in mice subjected to rAAV-IB␣ administration, thus strongly confirming the high efficiency of the rAAV for gene transfer to the heart. In mice treated with the reporter gene LacZ or PBS, the IB␣ levels in the cytoplasm began to decrease at 45 minutes of occlusion and peak reduction was observed at 1 hour of reperfusion. Thereafter IB␣ levels in cytoplasm increased, and after 5 hours of reperfusion the cardiac levels of the inhibitory protein were not significantly different from those of sham-operated animals (Fig. 3) . The rAAV-mediated gene transfer of IB␣ blunted the consistent loss of IB␣ protein from the cytoplasm (Fig. 3) . NF-B activation in the nuclear extracts of myocardium was determined by electrophoretic mobility shift assay (EMSA) in the myocardium-at-risk at different time points.
NF-B binding activity was present at low levels in sham-operated animals during occlusion and reperfusion. In mice treated with the reporter gene LacZ or PBS, NF-B rapidly increased at 0.5 hours of reperfusion and reached its peak increase after 2 hours of reperfusion (Fig. 4) . In fact NF-B binding activity was significantly higher at 2 hours than at 1 hour. The administration of rAAV-IB␣ markedly reduced NF-B binding activity (Fig. 4) . No significant changes of the p65/50 subunits versus 50/50 subunits were observed.
Intercellular Adhesion Molecule-1 (ICAM-1) mRNA Expression in the Myocardium-at-Risk of Mice Subjected to the rAAV-Mediated Gene Transfer of IBa
No significant change in cardiac ICAM-1 mRNA expression was observed during occlusion of the coronary artery. In mice treated with rAAV-LacZ or PBS, cardiac mRNA levels for ICAM-1 were significantly elevated during reperfusion ( adhesion molecule message were reached at 3 hours of reperfusion. ICAM-1 mRNA levels were, in fact, higher at 3 hours than at 2 hours. Administration of rAAV-IB␣ blunted cardiac ICAM-1 mRNA expression (Fig. 5) .
Discussion
Ischemia and reperfusion of the myocardium causes activation of NF-B, liberation of TNF-␣, and upregulation of ICAM-1, an adhesion molecule involved 
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in the accumulation of leukocytes in the ischemic tissues. As a consequence neutrophil adhesion may lead to aggravation and prolongation of the reperfusion injury (Kupatt et al, 1999) . NF-B is therefore critical for the transcription of multiple genes involved in MI/R injury, and it can be hypothesized that blocking NF-B would attenuate tissue damage. Using double-stranded oligodeoxynucleotides with a specific affinity for NF-B (decoy transfection against the transcription factor), a significant protection has been shown in experimental models of MI/R Sakaguchi et al, 2001; Sawa et al, 1997) .
Regulation of NF-B occurs through complex formation of the heterodimer with the cytoplasmic inhibitor IB␣. IB␣ retains the p50/p65 complex in the cytoplasm by masking its nuclear localization sequence (Zabel et al, 1993) . In addition to retaining NF-B in the cytoplasm, a second function has been demonstrated for IB␣: it can prevent DNA binding of NF-B, namely of the p50/p65 heterodimer (Brown et al, 1993) .
Taking advantage of this physiologic regulation of the early transcription factor, an approach to study the role of NF-B is the blockade of its activation by the transgene overexpression of its inhibitory protein IB␣. This approach may also be important to verify the potential of a gene therapy aimed at overexpressing the IB␣ protein for the treatment of myocardial ischemia.
Among the novel strategies that hold promise for gene therapy applications is the use of vectors based on the AAV. These vectors are derived from a nonpathogenic and widespread defective parvovirus and are able to transduce both dividing and nondividing cells in a variety of tissue including the heart (Monahan and Samulski, 2000) . More specifically it has been suggested that rAAV vectors show an exquisite tropism for cardiomyocytes (Melo et al, 2002; Phillips et al, 2002) . Because rAAV vectors are devoid of any viral genes (which are expressed in trans for the packaging process), they elicit virtually no inflammatory or immune response in the sites of injections. This represents an appealing feature for such a viral vector. In agreement with this hypothesis, our study confirms this idea: in fact rAAV-LacZ-treated animals and PBStreated mice had the same degree and extent of MI/R injury.
Ischemic and reperfused hearts treated with control vector (rAAV-LacZ) or PBS showed a marked nuclear binding of NF-B and reduced expression of the inhibitory protein IB␣. Maximum reduction of the cytoplasmic inhibitory protein was observed at 1 hour after the release of the coronary artery, whereas peak NF-B activation was achieved at 2 hours of reperfusion. Thereafter IB␣ protein levels and NF-B returned to basal levels, thus confirming that the transcription factor represents a rapid and early signal for controlling gene expression during reperfusion, as previously shown in an in vitro model of MI/R injury (Li et al, 1999) .
In keeping with this hypothesis, cardiac ICAM-1 mRNA levels started to increase at 1 hour of reperfusion and the peak for the adhesion molecule was reached after 3 hours of reperfusion. This confirms the hypothesis that NF-B activates an inflammatory cascade leading to the expression of cell adhesion molecules and cytokines, and, finally, culminating in the deleterious accumulation of leukocytes in the ischemic tissues. This latter event amplifies organ damage.
rAAV-mediated gene transfer of IB␣ efficiently caused a transgene expression of the inhibitory protein in the myocardium. Enhanced protein expression was still present 8 weeks after administration. This finding suggests that our rAAV-VEGF may be able to achieve a long-lasting effect that could confer longterm protection after myocardial ischemia with subsequent reperfusion. The feasibility of such a gene therapy for myocardial ischemia is further underlined and straightened by the exquisite tropism of rAAV for cardiomyocytes (Melo et al, 2002; Phillips et al, 2002) .
AAV-mediated gene delivery of IB␣ significantly reduced NF-B binding activity. Furthermore the IB␣ gene transfer blunted cardiac ICAM-1 expression, decreased leukocyte infiltration in the myocardium, and attenuated infarct size.
Therefore, this experimental evidence led us to hypothesize that gene delivery of the IB␣ protein may represent a promising strategy to interrupt the inflammatory cascade triggered by the transcription factor NF-B during MI/R injury. Indeed, this approach might represent an interesting alternative to the "pharmacological blockade" of NF-B in myocardial ischemia Chandrasekar et al, 2001b; Squadrito et al, 2000; Yoshiyama et al, 2001) .
Collectively, these data strongly support a key role of the early transcription factor NF-B in the development of myocardial injury after ischemia and reperfusion of the coronary arteries. Furthermore rAAVmediated gene transfer of IB␣ represents an interesting strategy for halting the inflammatory damage after myocardial reperfusion. However further studies on the efficacy and safety of rAAV-IB␣ must be performed before proposing this approach in the clinical setting.
Materials and Methods
Animals
All procedures complied with the standards for care and use of animal subjects as stated in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Bethesda, Maryland). Male C57BL/6 mice weighing 20 to 25 gm were used. The animals were bred in the Messina University School of Medicine Animal Facility.
rAAV Vector Preparation and Characterization
Two rAAV vectors were obtained in this study, expressing the LacZ reporter gene and the cDNA for IB␣ under the control of the strong and constitutive CMV immediate early promoter. These vectors were prepared as previously shown (Grimm et al, 1998; Zolotukhin et al, 1996) .
MI/R Injury
Male C57BL/6 mice were randomized to receive an rAAV encoding the gene for the NF-B inhibitory protein IB␣ (rAAV-IB␣) or the ␤-galactosidase gene (a control and inert gene; rAAV-LacZ), both at a dose of 10 11 copies. rAAV vectors in 50 l of PBS were injected into normal hearts at the left ventricle through the diaphragm via an incision on the upper abdomen (subdiaphragmatic approach). An additional group of animals received PBS alone (50 l). Three injections were performed under an echocardiographic guide that allowed the exact localization of the needle in the left ventricular myocardium. The echocardiographic study was performed by an ultrasonographer experienced in rodent imaging using commercially available equipment (Sonos 5500; Hewlett Packard Medical Products, Asndover, Massachusetts) and an 8-to12-MHz transducer. Four weeks later, animals were subjected to MI/R injury. After premedication with 0.04 mg/kg atropine sulfate im, animals were anesthetized with 100 mg/kg sodium pentobarbital ip. The animals were placed in a supine position with their paws and tails taped to the operating table. The head was retracted with a thin rubber band fastened to the upper incisors. The upper portion of the trachea was exposed through a middle incision in the neck, and the pretracheal muscles were bluntly dissected. A black tipped endotracheal tube, made with PE-50 tubing, was inserted by way of the mouth into the trachea with the black tip placed 5 to 8 mm below the thyroid cartilage. Artificial respiration was maintained through the use of a respirator with an FIO 2 of 0.80, a frequency of 100 strokes per minute, and a tidal volume of 0.8 to 1.2 mL, to maintain normal arterial PaO 2 , PaCO 2 , and pH. The middle skin incision in the neck was extended down to the xiphoid. The left pectoris major muscle and the muscle beneath it were dissected longitudinally, without cutting these muscles, to expose the left third and fourth ribs. A parasternal incision was made to open the chest by cutting the left third and fourth ribs with a cautery pen. Dissection was aided by a microscope (Zeiss, Jena, Germany). The animal was slightly rotated to the right through the release of the left upper paw to fully expose the left ventricle. The pericardial sac was then removed, and the LAD was visualized under microscope and ligated with a 7-0 silk suture using a snare occluder. To avoid injuring the LAD, a small patch was attached to its surface. Ischemia and reperfusion were accomplished by first tightening the snare occluder (45 minutes) and then loosening it. Significant electrocardiogram changes including widening of the QRS complex, peak S-T elevation in lead II (monitored with a MacLab/4E ECG module; AD Instruments, Hastings, UK), and color changes of the AAR were considered indicative of successful coronary occlusion and reperfusion. Once the reperfusion was started, the chest was closed in layers. The respirator was weaned and the endotracheal tube was removed when the animal recovered spontaneous breathing and began to move. Five percent dextrose and whole blood from animals with the same genotype were administered ip or iv to replace the fluid and blood loss that occurred during surgery. Reperfusion lasted 5 hours. Control animals underwent all of the previously described surgical procedures apart from the fact that the snare occluder was not tied (Sham MI/R).
Evaluation of Infarct Size
At the end of reperfusion period, the thoracotomies were reopened, the LAD was reoccluded, and 1 ml of 1.0% Evans Blue (Sigma Chemical Company, St. Louis, Missouri) was injected from the apex to each heart to delineate the nonischemic tissue. The AAR was therefore determined by negative staining. The heart were then excised, washed with PBS, and cut into five transverse slices. Sections were placed between two Plexiglas plates, and the outlines of the entire areas of the left ventricle and the unstained areas of the myocardium (ie, the AAR) were traced on transparencies. The slices were then placed in a 96-well culture plate, stained for 15 minutes at room temperature with 1.0 ml of 1.5% 2,3,5-triphenyltetrazolium chloride (Sigma Chemical Company) solution to determine the infarct size, weighed, and photographed under a microscope (Olimpus Company, Tokyo, Japan). Viable tissues stained deep red, and infarcted areas depleted of coenzyme and dehydrogenases were unstained. Left ventricle area, AAR, and infarct size were determined by computerized planimetry using Adobe Photoshop. The weight of the nonischemic area, AAR, and the infarction area were then calculated as a percentage of corresponding area multiplied by the weight of the slice.
Serum Creatine Phosphokinase Activity
Serum levels of creatine phosphokinase and its myocardium-specific isoform (CK-MB) were measured with the use of commercial kits (Sigma Chemical).
Cardiac ELA Content
ELA levels were evaluated as an index of polymorphonuclear neutrophil accumulation and activation in the jeopardized tissue because this enzyme is released from the stimulated granulocytes at the site of injury. The analysis was performed in the nonischemic area, AAR, and infarction area by using a specific immunoassay kit (PMN ELA, IMAC, Catalog No. 11332; Merck, Darmstadt, Germany) . ELA activity was expressed in microgram per gram (g/gm) of tissue.
Isolation of Nuclear and Cytoplasmic Proteins
Briefly 70 mg of pulverized myocardial samples (obtained from the AAR at different time points) were homogenized in 0.8 ml of ice cold hypotonic buffer [10 mM HEPES, pH 7.9; 0.1 mM EDTA; 0.1 mM EGTA; 1 mM Squadrito et al dithiothreitol; protease inhibitors: 0.5 mM phenyl methylsulfonyl fluoride, aprotinin, pepstatin, leupeptin (10 g/ml each); and phosphatase inhibitors: 50 mM NAF, 30 mM ␤-glycerophosphate, 1 mM Na 3 VO 4 , and 20 mM -nitrophenyl phosphate]. Nuclear and cytoplasmic proteins were isolated as previously reported (Altavilla et al, 2001 ).
Western Blot Analysis of IB␣ in Cytoplasm
Cytoplasmic proteins (20 g) from each sample were mixed with 2ϫ SDS sample buffer [62 mM Tris (pH 6.8), 10% glycerol, 2% SDS, 5% ␤-mercaptoethanol, 0.003% bromophenol blue], heated at 95°C for 5 minutes, and separated by SDS-PAGE. Western blot analysis of IB␣ in the cytoplasm was performed as previously reported Sawa et al (1997) . The IB␣ protein signal was quantified by scanning densitometry using a bio-image analysis system (BIO-PROFIL; Celbio, Milan, Italy). The results from each experimental group were expressed as relative integrated intensity compared with the sham MI/R group measured in the same batch.
EMSA NF-B binding activity was performed in a 15-l binding reaction mixture containing 1% binding buffer [50 g/ml of double-stranded poly(dI-dC), 10 mM Tris HCl (pH 7.5), 50 mM NaCl, 0.5 mM EDTA, 0.5 mM dithiothreitol, 1 mM MgCl 2 , and 10% glycerol], 15 g of nuclear proteins, and 35 fmol (50,000 cpm, Cherenkov counting) of double-stranded NF-B consensus oligonucleotide (5'-AGT TGA GGG GAC TTT CCC AGG C-8'; Promega, Madison, Wisconsin) which was endlabeled with [␥ 32 P]ATP (3000 Ci/mmol at 10 mCi/ml; Amersham Life Sciences, Arlington Heights, Illinois) using T4 polynucleotide kinase. This methodology has been previously described . The binding bands were quantified by scanning densitometry of a bio-image analysis system (BIO-PROFIL). The results for each time point from each group were expressed as relative integrated intensity compared with the sham MI/R group measured in the same batch because the integrated intensity of group samples from different EMSA batches would be affected by the half-life of the isotope, exposure time, and background levels.
RNA Isolation and RT-PCR
To evaluate the message for the ICAM-1, total cellular RNA was extracted from heart specimens (AAR) harvested from mice killed at different time points. The methodology has been previously reported .
The following oligonucleotide pairs were used (5' oligo/3' oligo), each sequence as 5' to 3': ICAM-1: AGGTGGATATCCGGTAGA/CCTTCTAAGTCCTCC-AACA; GAPDH: ACCACCATGGAGAAGGTCGG/CTCA-GTGTAGCCCAGGATGGC. The optimal cycle number for ICAM-1 was 25, and we used a PCR-negative and a PCR-positive control without cDNA or with a known cDNA, respectively. A portion of the PCR product was subjected to electrophoresis and transferred to a nylon membrane, which was prehybridized with oligonucleotide probes, radiolabeled with [ 32 P]ATP by a T4 oligonucleotide kinase. After an overnight hybridization at 55°C, filters underwent autoradiography in a dark room with a fixed camera. The captured image, sent to image analysis software (BIO-PROFIL) was subjected to densitometric analysis.
Statistical Analysis
Data are expressed as means Ϯ SD. The difference between the means of two groups was evaluated with an ANOVA followed by Bonferroni's test and was considered significant when p Ͻ 0.05.
